Back to search

Article

Selective Targeting of Pathological Angiogenesis via CPT2 Antagonism Mitigates Graft-versus-Host Disease

2026-06-02

Abstract excerpt

<title>Abstract</title> <p> Immunosuppressive treatments are broadly used to prevent or treat graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (alloSCT). The resulting severe treatment-related immunodeficiency is the main contributor to high alloSCT-associated mortality, highlighting the medical need for non-immunosuppressive strategies to prevent GVHD. Angiogenesis repre...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4c9a3e1f-a2dd-5e00-a781-0f2c6d45ff75
DOI
10.21203/rs.3.rs-9620419/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Selective Targeting of Pathological Angiogenesis via CPT2 Antagonism Mitigates Graft-versus-Host DiseaseDOI 10.21203/rs.3.rs-9620419/v1
Select a neighboring publication to make it the new centre.